Filtered By:
Management: Government
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 334 results found since Jan 2013.
‘This Is Really Life or Death.’ For People With Disabilities, Coronavirus Is Making It Harder Than Ever to Receive Care
Jeiri Flores is normally a busy, upbeat 29-year-old. But amid the COVID-19 pandemic, her go-to thought has been dark. “If I get this,” she thinks, “I’m gonna die.”
This is not an unfounded fear. Flores has cerebral palsy, uses a wheelchair and needs assistance with everyday tasks, including making food and getting dressed. Her disability means it’s tougher for her immune system to kick illnesses; she’s still recovering from a bout of pneumonia she had in January. So beating COVID-19 could easily mean a protracted battle and months in a hospital—a prospect that comes with a c...
Source: TIME: Health - April 24, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized COVID-19 Source Type: news
Philadelphia biotech firm battling Covid-19 gets $1M from federal health agency
The National Institute of Allergy and Infectious Diseases awarded Integral Molecular, a Philadelphia biotechnology company, $1 million to support its efforts to help in the battle against Covid-19.
Integral Molecular last month said it was seeking to apply its technology platforms to aid in the discovery of vaccines and therapeutics for the new coronavirus strain.
Benjamin Doranz, the company's president and CEO, said the financial support from the federal government agency will enable Inte gral…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 27, 2020 Category: Pharmaceuticals Authors: John George Source Type: news
Trial of Gilead ’ s Potential Coronavirus Treatment Running Ahead of Schedule
(Reuters)—A key U.S. government trial of Gilead Sciences Inc.’s experimental coronavirus treatment may yield results as early as mid-May, according to the study’s lead investigator, after doctors clamored to enroll their patients in the study. Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of Allergy... [Read More]
Source: The Rheumatologist - April 27, 2020 Category: Rheumatology Authors: Deena Beasley Tags: Drug Updates coronavirus COVID-19 Gilead remdesivir Source Type: research
Here ’s How Scientists and Public-Health Experts Recommend the U.S. Gets Back to ‘Normal’
There is both promise and peril in being a pioneer, and the people of Hokkaido have learned both lessons well over the past few months. After infections of COVID-19 on the Japanese island exploded following its annual winter festival this year, officials in February declared a state of emergency to control the disease. Soon after, new daily cases plummeted, and Hokkaido’s quick action was heralded as a beacon for the rest of Japan to follow.
But it wasn’t just infections that dropped; over the next month, agriculture and tourism business also dried up, and Hokkaido’s governor decided to ease social restri...
Source: TIME: Health - April 30, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news
Roche Scores EUA for COVID-19 Antibody Test
There were some pretty significant developments in the world of COVID-19 that occurred over the weekend. One of these developments was Roche Diagnostics being granted Emergency Use Authorization (EUA) for the Elecsys Anti-SARS-CoV-2 antibody test.
The antibody or serology test is designed to help determine if a patient has been exposed to the SARS-CoV-2 virus and if the patient has developed antibodies against SARS-CoV-2.
Roche said it has already started shipping the new antibody test to laboratories worldwide and will ramp up production capacity to high double-digit millions per month to serve healthcare systems in count...
Source: MDDI - May 4, 2020 Category: Medical Devices Tags: COVID-19 IVD Source Type: news
NIH experts: Coordinated strategy to accelerate COVID-19 vaccine candidates is key
(NIH/National Institute of Allergy and Infectious Diseases) A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science. As the COVID-19 pandemic continues, government, industry and academia have introduced a variety of vaccine candidates. The authors note that more than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2, the virus that causes COVID-19.
Source: EurekAlert! - Infectious and Emerging Diseases - May 11, 2020 Category: Infectious Diseases Source Type: news
Joe Biden Says He Would Tell Governors to ‘Listen to Dr. Fauci’ and ‘Facts’ if He Were President
Former Vice President Joe Biden said Tuesday morning that if he were President he would tell governors to “listen to Dr. [Anthony] Fauci,” the United States’ top infectious disease expert who testified before the Senate on Tuesday that reopening states prematurely risks creating new outbreaks of the virus.
“Do you believe states are opening up too quickly or too slowly?” George Stephanopoulos asked the Democratic presidential nominee Tuesday on Good Morning America. “If you were President right now, what would you be telling governors to do?”
“I would be telling governors to ...
Source: TIME: Health - May 12, 2020 Category: Consumer Health News Authors: Madeleine Carlisle Tags: Uncategorized COVID-19 News Desk Source Type: news
There Isn ’t a COVID-19 Vaccine Yet. But Some Are Already Skeptical About It
Amid the American flags, “Make America Great Again” hats and “freedom is essential” posters appearing at recent protests against coronavirus lockdowns in Sacramento, Calif., another familiar slogan has materialized: “We do not consent.” It’s long been a popular rallying cry among antivaccine activists, who claim without evidence that vaccines cause autism or other conditions. As the COVID-19 pandemic rages on, those activists have become intertwined with demonstrators who want businesses to reopen despite public health experts’ warnings.
Offline, the “anti-vaxxers”...
Source: TIME: Health - May 18, 2020 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news
How Remdesivir Moved From Back Shelf to Best Hope for Treating COVID-19
This study showed that a five-day regimen is as effective as 10 days–that’s important, doctors say, since it could mean shorter stays in the hospital, which could alleviate some of the burden on the health care system. “Of course we will have to wait for the final review of all the data, but it would be very nice to have an anti-viral that’s efficacious in this terrible illness,” says Dr. Aruna Subramanian, a clinical professor of medicine at Stanford and an investigator on the study. “At least we know that we can help patients with this, and that’s really the bottom line.”
T...
Source: TIME: Health - May 21, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 feature Magazine Source Type: news
Coronavirus Vaccine: Here Are The Latest Developments
(CNN) — While coronavirus keeps spreading and killing with impunity, the world waits for a vaccine that could quash the pandemic.
But details and timelines keep shifting. Here’s the latest on where we stand in the race for a vaccine:
When will a Covid-19 vaccine be available to the public?
No one’s sure yet, but the target is sometime in early 2021.
Vaccines in development around the world are in various stages of testing. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he’s confident one of the vaccine candidates will be proven safe and effective by th...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 8, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Closures Covid-19 Boston, MA Health Healthcare Status Coronavirus Coronavirus Vaccine Moderna Therapeutics Source Type: news
Is New York City Making a Huge Mistake by Reopening Right Now?
Imagine you’re the person in charge of reopening New York City, and you look at the below chart:
( function() {
var func = function() {
var iframe = document.getElementById('wpcom-iframe-2b3181d2ed5a5c1404959ba7022ec3f8')
if ( iframe ) {
iframe.onload = function() {
iframe.contentWindow.postMessage( {
'msg_type': 'poll_size',
'frame_id': 'wpcom-iframe-2b3181d2ed5a5c1404959ba7022ec3f8'
}, "https:\/\/embeds.time.com" );
}
}
// Autosize iframe
var funcSizeResponse = function( e ) {
var origin = document.createElement( 'a' );
origin.href = e.o...
Source: TIME: Health - June 8, 2020 Category: Consumer Health News Authors: Alex Fitzpatrick Tags: Uncategorized COVID-19 Source Type: news
Covid-19 Is Not Gender-Neutral
By Andrea UlrichJune 09, 2020As people around the world continue to face the effects of COVID-19, academic institutions and government policymakers are turning to data more than ever to understand the scope of the crisis, anticipate its spread, and formulate policy decisions.One example of existing high quality, real-time data is theJohns Hopkins’ COVID-19 dashboard, which has expanded as a data resource as the crisis grows. While policymakers and experts are relying on these resources, it is crucial to understand what information is being captured and what is not, as making decisions with incomplete or faulty data h...
Source: IntraHealth International - June 8, 2020 Category: International Medicine & Public Health Authors: cbishopp Tags: COVID-19 Digital Health Source Type: news
Moderna Plans To Start Phase 3 Testing of its COVID-19 Vaccine Candidate in July
This study will include more people who might be a high risk of exposure to COVID-19, such as health care workers and residents in long-term care facilities.
In June, Moderna became one of five vaccine developers chosen to be part of President Trump’s Operation Warp Speed program to speed development of a COVID-19 vaccine. The selection qualifies Moderna to receive federal government funding to continue development of vaccine, conduct tests, as well as scale up manufacturing to meet the goal of beginning to inoculate 300 million people beginning early next year. Moderna said it plans to deliver 500 million to 1 billi...
Source: TIME: Health - June 11, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
COVID-19 - guidance for acute settings, RCPCH (updated 18th June 2020)
This page provides guidance for paediatric emergency and acute settings. It has been produced with the Association of Paediatric Emergency Medicine (APEM) and the British Paediatric Allergy, Immunity and Infection Group (BPAIIG).
Updates in this version (18 June 2020)
Added link to RCPCH 2 External 0 0 0 guidance on resuscitation false https://www.rcpch.ac.uk/resources/covid-19-resuscitation-guide false false%>. Added link to 2 External 0 0 0 guidance for hospital visitors false https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/new-government-recommendations-...
Source: Current Awareness Service for Health (CASH) - June 19, 2020 Category: Consumer Health News Source Type: news
President Trump Is Working to Undermine Dr. Fauci Even as Coronavirus Cases Spike
(WASHINGTON) — With U.S. virus cases spiking and the death toll mounting, the White House is working to undercut its most trusted coronavirus expert, playing down the danger as President Donald Trump pushes to get the economy moving before he faces voters in November.
The U.S. has become a cautionary tale across the globe, with once-falling cases now spiraling. However, Trump suggests the severity of the pandemic that has killed more than 135,000 Americans is being overstated by critics to damage his reelection chances.
Trump on Monday retweeted a post by Chuck Woolery, once the host of TV’s “Love Connect...
Source: TIME: Health - July 14, 2020 Category: Consumer Health News Authors: Jill Colvin, Jonathan Lemire and Zeke Miller / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
